Patrick Aisher is the Chairman of Kinled Holding Limited, recognized by the Financial Times as one of Europe's leading health-tech investors. With a rich history in investment, Kinled has developed a portfolio of over 130 investments, achieving numerous successful exits and 22 IPOs. Aisher also serves as a director and investor for Aleva Neurotherapeutics SA and holds advisory roles in multiple companies, including Bricksave and Danube BioVentures. They are dedicated to fostering innovation in life sciences, digital technology, and financial technology, and have actively shaped the evolving biotech and pharmaceutical sectors. Aisher completed studies in Trust Management at the Society of Trust & Estate Professionals.
This person is not in the org chart
This person is not in any teams
This person is not in any offices